Albiglutide

Definition

A once-weekly GLP-1 receptor agonist marketed as Tanzeum by GSK. Approved by the FDA in 2014 for type 2 diabetes; withdrawn from global markets by GSK in 2017 due to low commercial uptake. The HARMONY OUTCOMES trial (Lancet 2018) demonstrated 22% MACE reduction — published after withdrawal.

HARMONY OUTCOMES trial →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in drug

• Liraglutide
• Exenatide
• Dulaglutide
• Contrave
• Qsymia
• Bupropion
• Naltrexone
• Phentermine
• Topiramate
• Pemvidutide
• Mazdutide

Looking for more depth?

• HARMONY OUTCOMES trial
• Browse the full GLP-1 glossary (124 terms across 8 categories)
• Research articles — primary-source deep dives
• Tools and calculators
• Compare GLP-1 telehealth providers